Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | nuclear factor, erythroid 2-like 2 | Starlite/ChEMBL | No references |
Homo sapiens | ubiquitin specific peptidase 1 | Starlite/ChEMBL | No references |
Homo sapiens | tumor protein p53 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus granulosus | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Echinococcus multilocularis | tumor protein p63 | Get druggable targets OG5_140038 | All targets in OG5_140038 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.0052 | 0.0788 | 0.2679 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0102 | 0.2091 | 0.7107 |
Mycobacterium ulcerans | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0164 | 0.3701 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.0788 | 0.0788 |
Brugia malayi | calcium-independent alpha-latrotoxin receptor 2, putative | 0.0032 | 0.0286 | 0.0972 |
Trichomonas vaginalis | galactokinase, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | homoserine kinase | 0.0021 | 0 | 0.5 |
Brugia malayi | hypothetical protein | 0.0043 | 0.0574 | 0.195 |
Trypanosoma cruzi | mevalonate kinase, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0286 | 0.2277 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.0788 | 0.0788 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0102 | 0.2091 | 0.7107 |
Trypanosoma brucei | phosphomevalonate kinase protein, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | galactokinase, putative | 0.0021 | 0 | 0.5 |
Wolbachia endosymbiont of Brugia malayi | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0164 | 0.3701 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0574 | 1 |
Leishmania major | phosphomevalonate kinase protein, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | cellular tumor antigen P53 | 0.006 | 0.0995 | 0.7924 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.0788 | 0.6278 |
Loa Loa (eye worm) | latrophilin receptor protein 2 | 0.0032 | 0.0286 | 0.0972 |
Toxoplasma gondii | GHMP kinase, N-terminal domain-containing protein | 0.0021 | 0 | 0.5 |
Plasmodium falciparum | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, putative | 0.0143 | 0.3151 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.007 | 0.1255 | 1 |
Echinococcus granulosus | GPCR family 2 | 0.0032 | 0.0286 | 0.0286 |
Brugia malayi | Latrophilin receptor protein 2 | 0.0032 | 0.0286 | 0.0972 |
Leishmania major | homoserine kinase, putative | 0.0021 | 0 | 0.5 |
Brugia malayi | MH2 domain containing protein | 0.0135 | 0.2942 | 1 |
Echinococcus multilocularis | Basic leucine zipper (bZIP) transcription | 0.0043 | 0.0574 | 0.0574 |
Leishmania major | mevalonate kinase, putative | 0.0021 | 0 | 0.5 |
Trichomonas vaginalis | galactokinase, putative | 0.0021 | 0 | 0.5 |
Trypanosoma cruzi | homoserine kinase | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | transcription factor LCR-F1 | 0.0043 | 0.0574 | 0.4571 |
Echinococcus granulosus | Basic leucine zipper bZIP transcription | 0.0043 | 0.0574 | 0.0574 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0995 | 0.3381 |
Giardia lamblia | Mevalonate kinase | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.0788 | 0.6278 |
Echinococcus multilocularis | tumor protein p63 | 0.0408 | 1 | 1 |
Echinococcus granulosus | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0286 | 0.0286 |
Trypanosoma cruzi | galactokinase, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0286 | 0.0286 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0574 | 1 |
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0135 | 0.2942 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0135 | 0.2942 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.0052 | 0.0788 | 0.0788 |
Treponema pallidum | hypothetical protein | 0.0164 | 0.3701 | 0.5 |
Chlamydia trachomatis | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 0.0152 | 0.3384 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0286 | 0.2277 |
Loa Loa (eye worm) | hypothetical protein | 0.0032 | 0.0286 | 0.0972 |
Trypanosoma brucei | mevalonate kinase, putative | 0.0021 | 0 | 0.5 |
Mycobacterium leprae | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0164 | 0.3701 | 0.5 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0574 | 1 |
Entamoeba histolytica | hypothetical protein | 0.0043 | 0.0574 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.0052 | 0.0788 | 0.6278 |
Echinococcus multilocularis | cadherin EGF LAG seven pass G type receptor | 0.0032 | 0.0286 | 0.0286 |
Plasmodium vivax | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase, putative | 0.0143 | 0.3151 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0102 | 0.2091 | 0.7107 |
Trypanosoma cruzi | galactokinase, putative | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0286 | 0.2277 |
Leishmania major | galactokinase-like protein | 0.0021 | 0 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0032 | 0.0286 | 0.2277 |
Trypanosoma brucei | homoserine kinase | 0.0021 | 0 | 0.5 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.007 | 0.1255 | 0.4267 |
Loa Loa (eye worm) | hypothetical protein | 0.007 | 0.1255 | 0.4267 |
Echinococcus multilocularis | GPCR, family 2 | 0.0032 | 0.0286 | 0.0286 |
Onchocerca volvulus | 0.006 | 0.0995 | 0.5 | |
Trichomonas vaginalis | galactokinase, putative | 0.0021 | 0 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.0052 | 0.0788 | 0.0788 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0102 | 0.2091 | 0.7107 |
Mycobacterium tuberculosis | Probable 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase IspE (CMK) (4-(cytidine-5'-diphospho)-2-C-methyl-D-erythritol kinase) | 0.0143 | 0.3151 | 1 |
Echinococcus multilocularis | diuretic hormone 44 receptor GPRdih2 | 0.0032 | 0.0286 | 0.0286 |
Schistosoma mansoni | hypothetical protein | 0.0043 | 0.0574 | 0.4571 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.0052 | 0.0788 | 0.2679 |
Toxoplasma gondii | GHMP kinase, putative | 0.0021 | 0 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.005 um | PUBCHEM_BIOASSAY: qHTS Screen for Compounds that Selectively Target Cancer Cells with p53 Mutations: Cytotoxicity of p53 Null Cells at the Nonpermissive Temperature. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 3.5481 uM | PubChem BioAssay. Inhibitors of USP1/UAF1: Primary Screen. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3601 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of Polymerase Iota. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588623] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.